Cycloserine induced delirium during treatment of multi-drug resistant tuberculosis (MDR-TB)

Abstract

Objective: To report about delirium related to Cycloserine. Method: Systematic assessment and management of a patient who developed delirium during the course of treatment for MDR-TB. Results: An association was found with the use of Cycloserine and development of delirium. The management of this case is described. Conclusion: Patients with MDR-TB receiving Cycloserine should be closely monitored for neuropsychiatric side effects for early recognition and treatment.

Keywords

• Cycloserine
• Multi-drug resistant tuberculosis
• Delirium